IKT Stock Closes at $2.41 In the Middle of Today's Range
Open: $2.48 High: $2.48 Low: $2.37 Close: $2.41 Why it matters: IKT finished in the middle of today's range.

Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics is a clinical-stage pharmaceutical company that develops small molecule kinase inhibitor therapeutics to treat pulmonary arterial hypertension and other infectious or cardiopulmonary diseases.
2026 Price Target
$6.00
Average analyst target
Currency
Monetary values are shown in your selected currency.
Friday, August 28
Low
$2.38
High
$2.47
Cost of Shares
—
Simulated Profit
—
Simulated results compare the selected period's low and high and do not represent an actual trade. Fees, taxes, slippage, and the ability to execute at exact prices are not included.
Reported Profit
$0
0 profit reports
Reported Loss
$0
0 loss reports
Net Reported
$0
0 total reports
No community outlook yet.
Be the first to vote when a poll becomes available.
Open: $2.48 High: $2.48 Low: $2.37 Close: $2.41 Why it matters: IKT finished in the middle of today's range.
IKT is trading lower today at $2.40 (-2.8%).
IKT opened today's regular trading session at $2.49, compared with its previous close of $2.47. Opening difference: +0.8% Why it matters: The stock began trading 0.8% above its previous close.
Community sentiment and reported results reflect voluntary member input and should not be interpreted as investment advice or verified performance.